Impact of the Innovative Medicines Initiative on vaccine development

Nat Rev Drug Discov. 2018 Nov;17(11):769-770. doi: 10.1038/nrd.2018.72. Epub 2018 Jun 1.

Authors

Philippe Denoel¹, Patricia Londoño-Hayes², Magda Chlebus³, Magdalena Rodriguez de Azero⁴

Affiliations

¹ GSK, Rixensart, Belgium.
² Sanofi Pasteur, Marcy-l'Étoile, France.
³ European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium.
⁴ Vaccines Europe/EFPIA, Brussels, Belgium.

PMID: 29853715
DOI: 10.1038/nrd.2018.72

No abstract available

MeSH terms

Drug Development / methods
Drug Industry / methods
Europe
Humans
Vaccines / chemistry*

Substances

Vaccines